Interaction of insulin hormone with neurotransmitters in the pathogenesis of Alzheimer's disease
Medical Sciences Journal of Islamic Azad University · 2026
DOI: 10.66224/iau.36.3.281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences Journal of Islamic Azad University, 2026. Verfasst von Sam Torabi Goodarzi und 2 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
The association between insulin resistance and Alzheimer's disease (AD) has been proposed as the "type 3 diabetes" hypothesis.This systematic review investigates the role of impaired cerebral insulin signaling in the pathogenesis of AD and its therapeutic prospects.Materials and methods: Following the PRISMA guidelines, a comprehensive search was conducted in PubMed/MEDLINE, Scopus, and Web of Science databases up to 2025.After screening, 32 studies were included in the review.
Results
Cerebral insulin resistance is a key pathological factor in AD that acts through independent mechanisms.It impairs amyloid-beta (Aβ) clearance by reducing the activity of insulin-degrading enzyme (IDE) and by disrupting the PI3K/Akt pathway, leads to GSK-3β activation and tau hyperphosphorylation.These processes, together with impaired neurotransmission and inflammation, form a vicious cycle of neurodegeneration and support the concept of type 3 diabetes.In contrast, emerging therapies such as intranasal insulin and GLP-1 agonists have shown potential to improve molecular markers and cognition in early studies.
Conclusion
Cerebral insulin resistance is an important and targetable causal component in the pathogenesis of AD.Targeting this pathway is a promising therapeutic strategy.However, challenges such as standardization of measurement, rigorous trial design, and crossing the blood-brain barrier require attention before widespread clinical application.Future research should focus on identifying biomarkers and developing combination therapies.
Zitieren
APA
Goodarzi, S. T., Layali, I., & Nematollah, Z. (2026). Interaction of insulin hormone with neurotransmitters in the pathogenesis of Alzheimer's disease. Medical Sciences Journal of Islamic Azad University. https://doi.org/10.66224/iau.36.3.281
Vancouver
Goodarzi ST, Layali I, Nematollah Z. Interaction of insulin hormone with neurotransmitters in the pathogenesis of Alzheimer's disease. Medical Sciences Journal of Islamic Azad University. 2026. doi:10.66224/iau.36.3.281
BibTeX
@article{Goodarzi2026,
author = {Goodarzi, Sam Torabi and Layali, Issa and Nematollah, Zahra},
title = {Interaction of insulin hormone with neurotransmitters in the pathogenesis of Alzheimer's disease},
journal = {Medical Sciences Journal of Islamic Azad University},
year = {2026},
doi = {10.66224/iau.36.3.281}
}
EUVIMED